The detection of myoclonus or visual or cerebellar findings was associated with shorter disease duration, as were elevations of CSF protein 14-3-3 and T-tau levels, suggesting that these variables may inform disease prognosis. The gene discussed is MAPT; the disease is Myoclonus.